Home/Hedge Fund Intelligence/Wave Life Sciences, Inc.
Nasdaq: WVEStockForm 13F30 Jun 2026

Hedge funds that hold Wave Life Sciences, Inc. Nasdaq: WVE

CUSIP Y95308105 · who reports it, how much, and how much it matters to them

30 of the 720 hedge fund managers we track reported shares of Wave Life Sciences, Inc. (Nasdaq: WVE) on Form 13F for 30 June 2026. Between them they reported USD 389m. The largest position belongs to Ra Capital Management, at USD 157m. The manager with the most riding on it is M28 Capital Management, where it is 56.5% of the reported book.

Managers reporting it30of 720 we track
Value they reportUSD 389mshares only, 30 Jun 2026
Funds they run360with a file on PPLI.com
Largest positionUSD 157mRa Capital Management
Typical weight0.0%median share of a manager's book
Heaviest weight56.5%M28 Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

30 managers, USD 389m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Wave Life Sciences, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Ra Capital Management1 fund on PPLI.comUSD 157m1.4%
2Maverick Capital20 funds on PPLI.comUSD 60m0.5%
3683 Capital Management2 funds on PPLI.comUSD 29m1.4%
4M28 Capital Management1 fund on PPLI.comUSD 27m56.5%
5Two Sigma Investments35 funds on PPLI.comUSD 22m0.0%
6Squarepoint Ops7 funds on PPLI.comUSD 15m0.0%
7Millennium Management6 funds on PPLI.comUSD 11m0.0%
8D. E. Shaw & Co.15 funds on PPLI.comUSD 10m0.0%
9Renaissance Technologies13 funds on PPLI.comUSD 9.9m0.0%
10POINT72 Asset Management17 funds on PPLI.comUSD 8.6m0.0%
11RTW Investments2 funds on PPLI.comUSD 7.8m0.1%
12Marshall Wace LLP84 funds on PPLI.comUSD 5.8m0.0%
13Baker Bros. Advisors2 funds on PPLI.comUSD 4.8m0.0%
14Capital Fund Management S.A.12 funds on PPLI.comUSD 4.3m0.0%
15Sphera Funds Management1 fund on PPLI.comUSD 3.7m0.5%
16Walleye Capital8 funds on PPLI.comUSD 3.4m0.0%
17Citadel Advisors32 funds on PPLI.comUSD 2.8m0.0%
18Platinum Investment Management11 funds on PPLI.comUSD 1.6m0.4%
19Exoduspoint Capital Management7 funds on PPLI.comUSD 1.5m0.0%
20Newtyn Management3 funds on PPLI.comUSD 1.2m0.2%
21Sofinnova Investments1 fund on PPLI.comUSD 1.1m0.1%
22Burkehill Global Management5 funds on PPLI.comUSD 872,0000.0%
23Boothbay Fund Management2 funds on PPLI.comUSD 842,0000.0%
24Jain Global1 fund on PPLI.comUSD 407,0000.0%
25Brevan Howard Capital Management39 funds on PPLI.comUSD 354,0000.0%
26Engineers Gate Manager1 fund on PPLI.comUSD 296,0000.0%
27Bayforest Capital1 fund on PPLI.comUSD 284,0000.3%
28Verition Fund Management3 funds on PPLI.comUSD 232,0000.0%
29Mirabella Financial Services LLP10 funds on PPLI.comUSD 140,0000.0%
30Graham Capital Management18 funds on PPLI.comUSD 125,0000.0%
Next: where it matters most
Where it matters most

For M28 Capital Management it is 56.5% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1M28 Capital ManagementUSD 27m56.5%
2683 Capital ManagementUSD 29m1.4%
3Ra Capital ManagementUSD 157m1.4%
4Maverick CapitalUSD 60m0.5%
5Sphera Funds ManagementUSD 3.7m0.5%
6Platinum Investment ManagementUSD 1.6m0.4%
7Bayforest CapitalUSD 284,0000.3%
8Newtyn ManagementUSD 1.2m0.2%
9RTW InvestmentsUSD 7.8m0.1%
10Sofinnova InvestmentsUSD 1.1m0.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Wave Life Sciences, Inc.

What is the ticker symbol of Wave Life Sciences, Inc.?

Wave Life Sciences, Inc. trades under the symbol WVE on the Nasdaq. Its CUSIP, the code used on Form 13F, is Y95308105.

Which hedge funds own Wave Life Sciences, Inc. (Nasdaq: WVE)?

30 of the 720 hedge fund managers PPLI.com tracks reported Wave Life Sciences, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 157m), Maverick Capital (USD 60m), 683 Capital Management (USD 29m), M28 Capital Management (USD 27m) and Two Sigma Investments (USD 22m).

How many hedge funds hold Wave Life Sciences, Inc.?

30 managers in our coverage reported it, and between them they run 360 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Wave Life Sciences, Inc.?

M28 Capital Management, where the position was 56.5% of the reported 13F book at 30 June 2026.

Does this show who is short Wave Life Sciences, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Wave Life Sciences, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.